Related references
Note: Only part of the references are listed.Multiple testing correction over contrasts for brain imaging
Bianca A. Alberton et al.
NEUROIMAGE (2020)
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Jyh Yung Hor et al.
FRONTIERS IN NEUROLOGY (2020)
Neuromyelitis optica spectrum disorders
Saif Huda et al.
CLINICAL MEDICINE (2019)
Density-weighted concentric rings k-space trajectory for H-1 magnetic resonance spectroscopic imaging at 7T
Mark Chiew et al.
NMR IN BIOMEDICINE (2018)
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias
James M. Joers et al.
ANNALS OF NEUROLOGY (2018)
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
Ruth Geraldes et al.
NATURE REVIEWS NEUROLOGY (2018)
Non-parametric combination and related permutation tests for neuroimaging
Anderson M. Winkler et al.
HUMAN BRAIN MAPPING (2016)
Physiological neuronal decline in healthy aging human brain - An in vivo study with MRI and short echo-time whole-brain 1H MR spectroscopic imaging
Xiao-Qi Ding et al.
NEUROIMAGE (2016)
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis
Niamh Cawley et al.
BRAIN (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
Stephane Kremer et al.
JAMA NEUROLOGY (2015)
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
Lucy Matthews et al.
PLOS ONE (2015)
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
Claudia F. Lucchinetti et al.
BRAIN PATHOLOGY (2014)
Magnetic Resonance Spectroscopy A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
David H. Miller
JAMA NEUROLOGY (2014)
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis
Sara Llufriu et al.
JAMA NEUROLOGY (2014)
Low Myo-Inositol Indicating Astrocytic Damage in a Case Series of Neuromyelitis Optica
Olga Ciccarelli et al.
ANNALS OF NEUROLOGY (2013)
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS
Ivan I. Kirov et al.
NEUROLOGY (2013)
Regional neurochemical profiles in the human brain measured by 1H MRS at 7 T using local B1 shimming
Uzay E. Emir et al.
NMR IN BIOMEDICINE (2012)
Neuromyelitis optica and astrocytic damage in its pathogenesis
Kazuo Fujihara
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Pain in neuromyelitis optica and its effect on quality of life A cross-sectional study
Y. Kanamori et al.
NEUROLOGY (2011)
Diffuse White Matter Damage Is Absent in Neuromyelitis Optica
F. Aboul-Enein et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica
Jerome de Seze et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Functional Changes in CSF Volume Estimated Using Measurement of Water T2 Relaxation
S. K. Piechnik et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
White matter spectroscopy in neuromyelitis optica A case control study
Denis Bernardi Bichuetti et al.
JOURNAL OF NEUROLOGY (2008)
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies
N. De Stefano et al.
NEUROLOGY (2007)
Long T2 water in multiple sclerosis:: What else can we learn from multi-echo T2 relaxation?
Cornelia Laule et al.
JOURNAL OF NEUROLOGY (2007)
MR evidence of long T2 water in pathological white matter
Cornelia Laule et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
N-acetylaspartate in the CNS:: From neurodiagnostics to neurobiology
John R. Moffett et al.
PROGRESS IN NEUROBIOLOGY (2007)
Brain abnormalities in neuromyelitis optica
SJ Pittock et al.
ARCHIVES OF NEUROLOGY (2006)
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter
H Vrenken et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis
KTM Fernando et al.
BRAIN (2004)
Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions
G Helms
MAGNETIC RESONANCE IN MEDICINE (2001)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)
Correlates of MS disability assessed in vivo using aggregates of MR quantities
C Mainero et al.
NEUROLOGY (2001)
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm
YY Zhang et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2001)
The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis - A serial diffusion MRI study
DJ Werring et al.
BRAIN (2000)
N-acetylaspartylglutamate:: The most abundant peptide neurotransmitter in the mammalian central nervous system
JH Neale et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
PA Brex et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)